GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Issuance of Stock

AngioLab (XKRX:251280) Issuance of Stock : ₩0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab Issuance of Stock?

AngioLab's Issuance of Stock for the six months ended in Dec. 2024 was ₩0 Mil.

AngioLab's Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0 Mil.


AngioLab Issuance of Stock Historical Data

The historical data trend for AngioLab's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Issuance of Stock Chart

AngioLab Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Stock
Get a 7-Day Free Trial - 5,499.99 - - -

AngioLab Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Stock Get a 7-Day Free Trial - 5,499.99 - - -

AngioLab Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AngioLab Issuance of Stock Related Terms

Thank you for viewing the detailed overview of AngioLab's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioLab Business Description

Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab Headlines

No Headlines